The article provides an overview of the joint replacement market’s performance and trends in 2026, noting that the industry continues to grow steadily following the recovery from pandemic-related slowdowns. Demand remains strong for hip and knee arthroplasty procedures due to an aging population and expanding indications for younger, active patients, while innovation in implant technology, surgical workflows, and digital tools (including robotics and data analytics) is reshaping competitive dynamics. Key market drivers highlighted include increased outpatient procedures, value-based care models, and expanded access in emerging regions, balanced against challenges such as cost pressures, supply chain constraints, and the need for robust clinical evidence to support new technologies. The piece underscores how major orthopedic OEMs and startups alike are investing in differentiated products and services to capture long-term growth in this evolving landscape.